Treatment of inflammatory diseases of the mammalian large intestine with cytoprotective prostaglandins
US4083998A · kind A · utility
2Cited by
3References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 17, 1976 |
| Grant date | Apr 11, 1978 |
| Priority date | — |
| Expiry date | Feb 17, 1996 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for treatment or prophylaxis of certain inflammatory diseases of the mammalian large intestine which comprises administrating a cytoprotective prostaglandin to a mammal who suffers from or is particularly susceptible to said inflammatory diseases of the large intestine. Cytoprotective prostaglandins refer to those prostaglandin-type compounds which are useful in reducing the incidence of NOSAC-induced lesions in the intestinal wall of the rat. "NOSAC" is an abbreviation for "nonsteroidal antiinflammatory compound. "
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.